Aromatase inhibitor “letrozole” versus progestin “norethisterone” in women with simple endometrial hyperplasia without atypia: A prospective cohort trial
Objective: To evaluate the effectiveness of the aromataze inhibitor “letrozole” to progestin “norethisterone” for women with simple endometrial hyperplasia without atypia. Subjects and methods: One hundred women with a histo-pathological diagnosis of simple endometrial hyperplasia without atypia wer...
Main Authors: | M. El-shamy, A. Gibreel, E. Refai, E. Sadek, A. Ragab |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2012-06-01
|
Series: | Middle East Fertility Society Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1110569011001129 |
Similar Items
-
Comparison the Effect of Letrozole Versus Medroxy Progesterone Acetate on Premenopausal Patients With Endometrial Hyperplasia: An Randomized clinical trial
by: Elham Rahmani, et al.
Published: (2017-07-01) -
Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
by: Oroma Nwanodi
Published: (2017-07-01) -
Prominent decidualization following progestin treatment for endometrial hyperplasia and carcinoma as a mimic of large residual tumor: A cautionary tale
by: Yang Hu, et al.
Published: (2021-05-01) -
Effectiveness and Safety of Very Low Dose Combined Oral Contraceptive for the Treatment of Non-atypical Endometrial Hyperplasia: A Pilot Study
by: Pichai Leerasiri, et al.
Published: (2006-05-01) -
The value of MRI in management of endometrial hyperplasia with atypia
by: Purushothaman Natarajan, et al.
Published: (2020-02-01)